Tests a blood cell measurement under controlled conditions
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study checks a physical measurement of how flexible your red blood cells are. It focuses on making sure the measurement is consistent and not accidentally changed by temperature or how long the sample sits before testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can have red blood cells tested more than once to check consistency
- The test team must be able to control or account for room temperature
- The timing of processing your blood sample must be controlled
- You can provide a blood sample that can be handled quickly and consistently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood cells (apheresis) from healthy volunteers to help develop new medicines. It checks your overall health to make sure you're a safe donor.
This study checks whether a detailed blood-cell test can help diagnose myelodysplastic syndrome (MDS), a bone marrow condition that can cause low blood counts. Your results are compared with standard bone marrow testing to see how well the blood test performs.
This study collects a type of blood cell called single nucleated cells from healthy volunteers to see what affects the collection. It may help researchers learn how to improve future treatments.
This trial is a tissue and blood bank that collects samples for future research. You may be asked to give blood and/or tissue again later, but it is meant to be done without interfering with your care.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
This study collects blood samples over time from adults with certain blood cancers to better understand why treatments stop working. It may help researchers improve how future therapies are chosen for patients whose disease becomes resistant.
Hear when a new Drepanocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.